{"id":58385,"date":"2023-03-22T10:00:29","date_gmt":"2023-03-22T14:00:29","guid":{"rendered":"https:\/\/www.ino.com\/blog\/?p=58385"},"modified":"2023-03-22T09:42:42","modified_gmt":"2023-03-22T13:42:42","slug":"the-port-we-need-in-this-market-storm","status":"publish","type":"post","link":"https:\/\/wwwtest.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/","title":{"rendered":"The Port We Need In This Market Storm"},"content":{"rendered":"

Editor\u2019s Note: Our experts here at INO.com cover a lot of investing topics and great stocks every week. To help you make sense of it all, every Wednesday we\u2019re going to pick one of those stocks and use Magnifi Personal<\/em> to compare it with its peers or competitors. Here we go\u2026<\/em><\/p>\n

\n

When markets turn as volatile and uncertain as they\u2019ve been this week, it\u2019s a good idea to look for sectors you\u2019d want to be invested in no matter where the markets go.<\/p>\n

Healthcare is one such sector.<\/p>\n

It encompasses two contrasting types of businesses. The first is boring, large-cap stocks in the pharmaceutical and healthcare services sectors. These traditionally provide some defensive qualities if the economy starts to slow. That\u2019s true because a lot of healthcare spending is not dependent on cycles in the economy. People get sick no matter the economy.<\/p>\n

The more exciting part of the healthcare sector is very growth-oriented, with high valuation multiples. This is the biotechnology sector, with exciting fields like genomics, CRSPR gene-editing machines, and cures for cancer.<\/p>\n

And even beyond biotech, there are also other growth segments in this healthcare sector, including medical data businesses and medical equipment suppliers. All of these are riding long-term trends such as aging and increased healthcare spending, along with big data and AI.<\/p>\n

<\/div>\n

The safer pharma sector looks especially enticing for more conservative investors. Vincent Deluard, strategist at StoneX, has run numbers showing pharmaceuticals have maintained 15% to 20% margins over the past 40 years. He told the Financial Times<\/em>: \u201cThey have almost no exposure to energy and basic material costs: their main expenses are research and development, marketing and lobbying\u2026 Inflation in drugs prices and medical services has been twice that of the broad consumer price index in the past 40 years.\u201d<\/em><\/p>\n

But for the adventurous among you, putting money into the more exciting biotech small caps may be the way to go. Valuations are cheap, with a substantial upside.<\/p>\n

So, I asked Magnifi Personal<\/em> to compare an ETF from each healthcare segment - pharma and biotech. I didn\u2019t even have to find the right ETFs. <\/p>\n

All I had to do was ask Magnifi Personal<\/em> to \u201cCompare pharma to biotech<\/a>\u201d and the investing AI helpfully picked the two largest ETFs in each sector, based on total assets: VanEck Pharmaceutical ETF (PPH) and iShares Biotechnology ETF (IBB).<\/p>\n

To have the Magnifi Personal<\/em> investing AI do this for you, ask it for more details, or expand the search by asking something like \u201cCompare pharma to energy<\/a>,\u201d just click here to start a 90-day free trial<\/a>! <\/p>\n

This ability to have an investing AI pore over reams of data for you in seconds and spit out an easy-to-understand comparison of two or more stocks is an invaluable tool in deciding where to invest next.<\/p>\n

We highly recommend you try it out. Click here to see how.<\/a><\/p>\n

Here\u2019s what Magnifi Personal<\/em> showed me after I typed in \u201cCompare pharma to biotech<\/a>\u201d:<\/p>\n

\"Compare<\/a><\/p>\n

This is an example of a response using Magnifi Personal<\/em>. This image is not a recommendation or individual advice. Please see bottom disclaimer for additional information, including INO\u2019s relationship with Magnifi.<\/em><\/p>\n

As you can see, on the short one-year time frame, the two ETFs come out equal. Pharma is less volatile, but also has lower returns than biotech.<\/p>\n

This is just a starting point, of course. Magnifi Personal<\/em> can easily compare the two ETFs on more criteria, such as dividend payments, turnover, how large the ETFs are, and so on. <\/p>\n

Explore all the options, or have the Magnifi Personal<\/em> investing AI start a new research journey for you by clicking here to start a 90-day free trial<\/a>!<\/p>\n

To get a clearer picture of how pharmaceuticals compare to biotech, I asked Magnifi Personal<\/em> to expand the timeframe from one year to three years. The results are pretty clear:<\/p>\n

\"Compare<\/a><\/p>\n

This is an example of a response using Magnifi Personal<\/em>. This image is not a recommendation or individual advice. Please see bottom disclaimer for additional information, including INO\u2019s relationship with Magnifi.<\/em><\/p>\n

<\/div>\n

Over the course of the pandemic, pharma stocks have generated higher returns with less volatility than the more speculative biotech stocks. With uncertain times ahead, the same might be happening going forward.<\/p>\n

Magnifi Personal<\/em> makes research like this as simple as typing a question. You can easily do this yourself, or ask Magnifi Personal<\/em> to add other measures to the comparison, including dividend, valuation metrics such as P\/E or P\/B ratios, gross margin, and more. Just click here<\/a> to see how to set up your Magnifi Personal<\/em> account!<\/p>\n

Latest from Magnifi Learn<\/a>: In today\u2019s volatile market, every investor\u2019s nest egg is on the line, so it\u2019s no surprise that 80 percent of Americans believe that personalized advice will help them meet their financial goals. Because they don\u2019t just want DIY instructions, AI could be the key to unlock their goals.<\/p>\n

\n

INO.com, a division of TIFIN Group LLC, is affiliated with Magnifi via common ownership. INO.com will receive cash compensation for referrals of clients who open accounts with Magnifi.<\/span><\/p>\n

Magnifi LLC does not charge advisory fees or transaction fees for non-managed accounts. Clients who elect to have Magnifi LLC manage all or a portion of their account will be charged an advisory fee. Magnifi LLC receives compensation from product sponsors related to recommendations. Other fees and charges may apply.<\/span><\/p>\n

Diversification does not guarantee a profit or protect against a loss in a declining market. It is a method used to help manage investment risk.<\/span><\/p>\n

Mutual Funds and Exchange Traded Funds (ETFs) are sold by prospectus. Please consider the investment objectives, risks, charges, and expenses carefully before investing. The prospectus, which contains this and other information about the investment company, can be obtained from the Fund Company or your financial professional. Be sure to read the prospectus carefully before deciding whether to invest.<\/b><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Editor\u2019s Note: Our experts here at INO.com cover a lot of investing topics and great stocks every week. To help you make sense of it all, every Wednesday we\u2019re going to pick one of those stocks and use Magnifi Personal to compare it with its peers or competitors. Here we go\u2026 When markets turn as […]<\/p>\n","protected":false},"author":41,"featured_media":52948,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[4549,32025,32046,32051],"class_list":["post-58385","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-biotech","tag-magnifi-personal","tag-midweek-matchup","tag-pharma"],"yoast_head":"\nThe Port We Need In This Market Storm - INO.com Trader's Blog<\/title>\n<meta name=\"description\" content=\"We're going to use the Magnifi Personal investing AI to compare an ETF from each healthcare segment - pharma and biotech.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Port We Need In This Market Storm - INO.com Trader's Blog\" \/>\n<meta property=\"og:description\" content=\"We're going to use the Magnifi Personal investing AI to compare an ETF from each healthcare segment - pharma and biotech.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/\" \/>\n<meta property=\"og:site_name\" content=\"INO.com Trader's Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/inocom\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-22T14:00:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-22T13:42:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"The INO.com Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"The INO.com Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/\"},\"author\":{\"name\":\"The INO.com Team\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280\"},\"headline\":\"The Port We Need In This Market Storm\",\"datePublished\":\"2023-03-22T14:00:29+00:00\",\"dateModified\":\"2023-03-22T13:42:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/\"},\"wordCount\":992,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg\",\"keywords\":[\"Biotech\",\"Magnifi Personal\",\"Midweek Matchup\",\"pharma\"],\"articleSection\":[\"General\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/\",\"url\":\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/\",\"name\":\"The Port We Need In This Market Storm - INO.com Trader's Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg\",\"datePublished\":\"2023-03-22T14:00:29+00:00\",\"dateModified\":\"2023-03-22T13:42:42+00:00\",\"description\":\"We're going to use the Magnifi Personal investing AI to compare an ETF from each healthcare segment - pharma and biotech.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#primaryimage\",\"url\":\"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg\",\"contentUrl\":\"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg\",\"width\":1200,\"height\":628,\"caption\":\"HealthEquity\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ino.com\/blog\/#website\",\"url\":\"https:\/\/www.ino.com\/blog\/\",\"name\":\"INO.com Trader's Blog\",\"description\":\"Expert Charts, Trading Tips and Technical Analysis from INO.com\",\"publisher\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ino.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ino.com\/blog\/#organization\",\"name\":\"INO.com Trader's Blog\",\"url\":\"https:\/\/www.ino.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg\",\"contentUrl\":\"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg\",\"width\":400,\"height\":472,\"caption\":\"INO.com Trader's Blog\"},\"image\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/inocom\/\",\"https:\/\/www.linkedin.com\/company-beta\/1056449\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280\",\"name\":\"The INO.com Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg\",\"caption\":\"The INO.com Team\"},\"url\":\"https:\/\/wwwtest.ino.com\/blog\/author\/the-ino-com-team\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"The Port We Need In This Market Storm - INO.com Trader's Blog","description":"We're going to use the Magnifi Personal investing AI to compare an ETF from each healthcare segment - pharma and biotech.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/","og_locale":"en_US","og_type":"article","og_title":"The Port We Need In This Market Storm - INO.com Trader's Blog","og_description":"We're going to use the Magnifi Personal investing AI to compare an ETF from each healthcare segment - pharma and biotech.","og_url":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/","og_site_name":"INO.com Trader's Blog","article_publisher":"https:\/\/www.facebook.com\/inocom\/","article_published_time":"2023-03-22T14:00:29+00:00","article_modified_time":"2023-03-22T13:42:42+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg","type":"image\/jpeg"}],"author":"The INO.com Team","twitter_card":"summary_large_image","twitter_misc":{"Written by":"The INO.com Team","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#article","isPartOf":{"@id":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/"},"author":{"name":"The INO.com Team","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280"},"headline":"The Port We Need In This Market Storm","datePublished":"2023-03-22T14:00:29+00:00","dateModified":"2023-03-22T13:42:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/"},"wordCount":992,"commentCount":0,"publisher":{"@id":"https:\/\/www.ino.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#primaryimage"},"thumbnailUrl":"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg","keywords":["Biotech","Magnifi Personal","Midweek Matchup","pharma"],"articleSection":["General"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/","url":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/","name":"The Port We Need In This Market Storm - INO.com Trader's Blog","isPartOf":{"@id":"https:\/\/www.ino.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#primaryimage"},"image":{"@id":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#primaryimage"},"thumbnailUrl":"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg","datePublished":"2023-03-22T14:00:29+00:00","dateModified":"2023-03-22T13:42:42+00:00","description":"We're going to use the Magnifi Personal investing AI to compare an ETF from each healthcare segment - pharma and biotech.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ino.com\/blog\/2023\/03\/the-port-we-need-in-this-market-storm\/#primaryimage","url":"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg","contentUrl":"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2020\/09\/healthcare-costs.jpg","width":1200,"height":628,"caption":"HealthEquity"},{"@type":"WebSite","@id":"https:\/\/www.ino.com\/blog\/#website","url":"https:\/\/www.ino.com\/blog\/","name":"INO.com Trader's Blog","description":"Expert Charts, Trading Tips and Technical Analysis from INO.com","publisher":{"@id":"https:\/\/www.ino.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ino.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ino.com\/blog\/#organization","name":"INO.com Trader's Blog","url":"https:\/\/www.ino.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg","contentUrl":"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg","width":400,"height":472,"caption":"INO.com Trader's Blog"},"image":{"@id":"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/inocom\/","https:\/\/www.linkedin.com\/company-beta\/1056449\/"]},{"@type":"Person","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280","name":"The INO.com Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg","caption":"The INO.com Team"},"url":"https:\/\/wwwtest.ino.com\/blog\/author\/the-ino-com-team\/"}]}},"_links":{"self":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/posts\/58385"}],"collection":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/comments?post=58385"}],"version-history":[{"count":0,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/posts\/58385\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/media\/52948"}],"wp:attachment":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/media?parent=58385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/categories?post=58385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/tags?post=58385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}